Cited by 299Cardiovascular Syncope and Autonomic DisordersCardiac pacing and defibrillation studiesHeart Rate Variability and Autonomic Control

The DOI matches its Crossref record, with a small difference in title or year; 24 of the 24 references it cites were found in a registry or an index.

Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope: A Multicenter, Randomized, Controlled Trial

Abstract

Background —This clinical investigation was performed to compare the effects of permanent dual-chamber cardiac pacing with pharmacological therapy in patients with recurrent vasovagal syncope. Methods and Results —Patients from 14 centers were randomized to receive either a DDD pacemaker provided with rate-drop response function or the β-blocker atenolol at the dosage of 100 mg once a day. Inclusion criteria were age >35 years, ≥3 syncopal spells in the preceding 2 years, and positive response to tilt table testing with syncope occurring in association with relative bradycardia. The primary outcome was the first recurrence of syncope after randomization. Enrollment was started in December 1997, and the first formal interim analysis was performed on July 30, 2000. By that time, 93 patients (38 men and 55 women; mean age, 58.1±14.3 years) had been enrolled and randomized, although follow-up data were available for all patients (46 patients in the pacemaker arm, 47 patients in the pharmacological arm). The interim analysis showed a significant effect in favor of permanent cardiac pacing (recurrence of syncope in 2 patients [4.3%] after a median of 390 days) compared with medical treatment (recurrence of syncope in 12 patients [25.5%] after a median of 135 days; OR, 0.133; 95% CI, 0.028 to 0.632; P =0.004). Consequently, enrollment and follow-up were terminated. Conclusions —DDD pacing with rate-drop response function is more effective than β-blockade for the prevention of syncopal recurrences in highly symptomatic vasovagal fainters with relative bradycardia during tilt-induced syncope.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hc2601.091708

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 5

  1. Sheldon R. Role of pacing in the treatment of vasovagal syncope. Am J Cardiol. 1999;84:26Q–32Q.
  2. 10.1161/circ.100.11.1242 · DOI
  3. Calkins H. Pharmacologic approaches to the therapy for vasovagal syncope. Am J Cardiol. 1999;84:20Q–25Q.
  4. 10.1161/circ.102.3.294 · DOI
  5. 10.1161/circ.93.5.973 · DOI

Cited by

Sorted by citations

Items 201–297 of 297

Metadata

Authors
Ammirati, F., Colivicchi, F., & Santini, M.
Affiliations
Ospedale San Filippo Neri (IT)
Corresponding author
Ammirati, Fabrizio
Venue
Circulation
Published
2001-07-03
Volume
104
Issue
1
Pages
52-57
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3021591942
Cited by
299
References
24
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 11 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 13 · 2016: 8 · 2015: 11 · 2014: 17 · 2013: 18 · 2012: 16
FWCI
18.86
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
vasovagal syncope, recurrent syncope, permanent cardiac pacing, DDD pacemaker, atenolol, beta-blockers, bradycardia, tilt table test, syncope prevention
MeSH terms
Anti-Arrhythmia Agents, Atenolol, Electrocardiography, Female, Follow-Up Studies, Heart Function Tests, Humans, Male, Middle Aged, Prospective Studies, Cohort Studies, Treatment Outcome, Defibrillators, Implantable, Disease-Free Survival, Tilt-Table Test, Syncope, Vasovagal, Endpoint Determination, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review